Clinical Ophthalmic Oncology

Retinoblastoma
3rd Auflage 2019
ISBN: 978-3-030-11122-9
Verlag: Springer International Publishing

Buch, Englisch, 303 Seiten, HC runder Rücken kaschiert, Format (B × H): 183 mm x 260 mm, Gewicht: 1056 g

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations.

Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.

Zielgruppe

Upper undergraduate

Autoren/Hrsg.

Berry, Jesse L.

Singh, Arun D.

Kim, Jonathan W.

Damato, Bertil E.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Augenheilkunde, Optometrie

Inhaltsverzeichnis

Retinoblastoma: Evaluation and Diagnosis

Differential Diagnosis of Leukocoria

Retinoblastoma: Staging and Grouping

Retinoblastoma: Incidence and Etiologic Factors

Retinoblastoma: An International Perspective

Retinoblastoma Tumorigenesis

Animal Models in Retinoblastoma Research

Retinocytoma or Retinoma

Retinoblastoma: Genetic Counseling and Testing

Retinoblastoma: Treatment Options

Retinoblastoma: Focal Therapy – Laser Treatment and Cryotherapy

Retinoblastoma: Focal Therapies: Brachytherapy

Retinoblastoma: Intravenous Chemotherapy

Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

Retinoblastoma: Intravitreal chemotherapy

Retinoblastoma: External beam radiation

Retinoblastoma: Enucleation

Retinoblastoma: Evolving Therapies

Histopathologic Features and Prognostic Factors

Orbital Retinoblastoma: Diagnosis and Management

Retinoblastoma: Metastatic Disease

Non ocular tumors and other long term complications

Trilateral Retinoblastoma

Screening Children at Risk for Retinoblastoma

Children’s Oncology Group (COG) Trials for Retinoblastoma

Social Aspects, Advocacy and Organizations


Retinoblastoma: Metastatic Disease

Non-ocular Tumors
Trilateral Retinoblastoma

Children’s Oncology Group (COG) Trials for Retinoblastoma

Über Autor(innen)

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects.
Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.
Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology.




Jesse L. Berry, MD

Assistant Professor of Clinical Ophthalmology

USC Roski Eye Institute

Children's Hospital Los Angeles

Keck School of Medicine of USC
1975 Zonal Ave, Los Angeles



California, USA



Jonathan W. Kim, MD

Director of Retinoblastoma Program, Children's Hospital Los Angeles

Associate Professor of Clinical Ophthalmology

Department of Ophthalmology

USC Roski Eye Institute

Keck School of Medicine of USC

1975 Zonal Ave, Los Angeles



California, USA

Bertil E. Damato, MD, PhD

Professor of Ophthalmology and Radiation Oncology


University of Oxford


Nuffield Department of Clinical Neurosciences


John Radcliffe Hospital


Oxford, UK

Arun D. Singh, MD

Professor of Ophthalmology

Editor, Ocular Oncology and Pathology

Director, Dept. of Ophthalmic Oncology

Cole Eye Institute, Cleveland Clinic

9500 Euclid Avenue, Cleveland

Ohio, USA